Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 4, 2014, Pages 756-763

  Wetmore, James B ^a   Phadnis, Milind A ^a   Mahnken, Jonathan D ^a   Ellerbeck, Edward F ^a   Rigler, Sally K ^a   Zhou, Xinhua ^a   Shireman, Theresa I ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN HEMORRHAGE; COMORBIDITY; DIALYSIS; ETHNICITY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RACE DIFFERENCE; SENSITIVITY ANALYSIS; AFRICAN AMERICAN; ANCESTRY GROUP; CAUCASIAN; CEREBRAL HEMORRHAGE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEMOGRAPHY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; INCIDENCE; KIDNEY FAILURE, CHRONIC; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STROKE; TIME; UNITED STATES;

AFRICAN AMERICANS; AGED; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL DIALYSIS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 84908486032     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06980713     Document Type: Article

References (37)

1. United States Renal Data System: USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012.
2. Tomaszewski A, Kutarski A, Tomaszewski M: [Fibrotic tissue reflecting lead course after percutaneous leads extraction]. Kardiol Pol 69: 619–620, 2011.
3. Xu PQ, Gong JP: [Effect of all trans retinoid acid (ATRA) on differentiation and apoptosis of HL-60 cell]. Chin J Cancer 23: 118– 123, 2004.
4. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G, Investigators R; REGARDS Investigators: Association of race and sex with risk of incident acute coronary heart disease events. JAMA 308: 1768–1774, 2012.
5. Rutten-Jacobs LC, Arntz RM, Maaijwee NA, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, de Leeuw FE: Long-term mortality after stroke among adults aged 18 to 50 years. JAMA 309: 1136–1144, 2013.
6. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA: Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol 24: 1166–1173, 2013.
7. Romero JR, Wolf PA: Epidemiology of Stroke: Legacy of the Fra-mingham Heart Study. Global heart 8: 67-75, 2013.
8. Baber U, Gutierrez OM, Levitan EB, Warnock DG, Farkouh ME, Tonelli M, Safford MM, Muntner P: Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers. Am Heart J 166: 373-380 e372, 2013.
9. Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L: Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26: 379–385, 2011.
10. Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4: 1611–1619, 2009.
11. Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis MA, Rigler SK, Spertus JA, Zhou X, Mukhopadhyay P, Shireman TI: Stroke and the “stroke belt” in dialysis: Contribution of patient characteristics to ischemic stroke rate and its geographic variation. J Am Soc Nephrol 24: 2053–2061, 2013.
12. Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis M, Rigler SK, Mukhopadhyay P, Spertus JA, Zhou X, Hou Q, Shireman TI: Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol 23: 112–118, 2013.
13. Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64: 603–609, 2003.
14. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO: Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14: 2623–2631, 2003.
15. Power A, Chan K, Singh SK, Taube D, Duncan N: Appraising stroke risk in maintenance hemodialysis patients: A large single-center cohort study. Am J Kidney Dis 59: 249–257, 2012.
16. Nicholas SB, Kalantar-Zadeh K, Norris KC: Racial disparities in kidney disease outcomes. Semin Nephrol 33: 409–415, 2013.
17. Wheeler SB, Reeder-Hayes KE, Carey LA: Disparities in breast cancer treatment and outcomes: Biological, social, and health system determinants and opportunities for research. Oncologist 18: 986–993, 2013.
18. 18. Wetmore JB, Mahnken JD, Mukhopadhyay P, Hou Q, Ellerbeck EF, Rigler SK, Spertus JA, Shireman TI: Geographic variation in ardio protective antihypertensive medication usage in dialysis patients. Am J Kidney Dis 58: 73–83, 2011.
19. Wetmore JB, Mahnken JD, Rigler SK, Ellerbeck EF, Mukhopadhyay P, Spertus JA, Hou Q, Shireman TI: The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients. Kidney Int 81: 469–476, 2012.
20. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ: An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 77: 141–151, 2010.
21. Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS, Goldberg RJ, Gurwitz JH: A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf 21[Suppl 1]: 100–128, 2012.
22. McCulloch C, Searle S: Generalized, Linear, and Mixed Models, New York, John Wiley & Sons, Inc., 2001.
23. Wetmore JB, Rigler SK, Mahnken JD, Mukhopadhyay P, Shireman TI: Considering health insurance: How do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? Nephrol Dial Transplant 25: 198–205, 2010.
24. Howard G, Labarthe DR, Hu J, Yoon S, Howard VJ: Regional differences in African Americans’ high risk for stroke: The remarkable burden of stroke for Southern African Americans. Ann Epidemiol 17: 689–696, 2007.
25. Sonel AF, Good CB, Mulgund J, Roe MT, Gibler WB, Smith SC Jr, Cohen MG, Pollack CV Jr, Ohman EM, Peterson ED; CRUSADE Investigators: Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: Insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 111: 1225–1232, 2005.
26. Sheats N, Lin Y, Zhao W, Cheek DE, Lackland DT, Egan BM: Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis 15: 25–32, 2005.
27. Riehle JF, Lackland DT, Okonofua EC, Hendrix KH, Egan BM: Ethnic differences in the treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich) 7: 445–454, 2005.
28. Qato DM, Lindau ST, Conti RM, Schumm LP, Alexander GC: Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf 19: 834–842, 2010.
29. Olomu AB, Grzybowski M, Ramanath VS, Rogers AM, Vautaw BM, Chen B, Roychoudhury C, Jackson EA, Eagle KA; American Collegeof Cardiology Foundation Guidelines Applied in Practice Steering Committee: Evidence of disparity in the application of quality improvement efforts for the treatment ofacute myocardial infarction: The American College of Cardiology’s Guidelines Applied in Practice Initiative in Michigan. Am Heart J 159: 377– 384, 2010.
30. Vulic D, Lee BT, Dede J, Lopez VA, Wong ND: Extent of controlof cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: From a 2005-2006 national survey. Am J Cardiovasc Drugs 10: 109–114, 2010.
31. Mehta JL, Bursac Z, Mehta P, Bansal D, Fink L, Marsh J, Sukhija R, Sachdeva R: Racial disparities in prescriptions for car-dioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals. Am J Cardiol 105: 1019–1023, 2010.
32. Poon I, Lal LS, Ford ME, Braun UK: Racial/ethnic disparities in medication use among veterans with hypertension and de-mentia:Anational cohortstudy. Ann Pharmacother 43: 185–193, 2009.
33. Litaker D, Koroukian S, Frolkis JP, Aron DC: Disparities among the disadvantaged: Variation in lipid management in the Ohio Medicaid program. Prev Med 42: 313–315, 2006.
34. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM: Predictors of delayed transition from central venous catheter useto permanent vascularaccess among ESRDpatients. Am J Kidney Dis 49: 276–283, 2007.
35. Hopson S, Frankenfield D, Rocco M, McClellan W: Variability in reasons for hemodialysis catheter use by race, sex, and geography: Findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis 52: 753–760, 2008.
36. Kalantar-Zadeh K: What is so bad about reverse epidemiology anyway? Semin Dial 20: 593–601, 2007.
37. Eggers PW: CMS 2728: What good is it? Clin J AmSoc Nephrol 5: 1908–1909, 2010.